ATE66367T1 - Verfahren zur herstellung von festen nifedipinzusammensetzungen mit verzoegerter abgabe und so erhaltene zusammensetzungen. - Google Patents

Verfahren zur herstellung von festen nifedipinzusammensetzungen mit verzoegerter abgabe und so erhaltene zusammensetzungen.

Info

Publication number
ATE66367T1
ATE66367T1 AT86201704T AT86201704T ATE66367T1 AT E66367 T1 ATE66367 T1 AT E66367T1 AT 86201704 T AT86201704 T AT 86201704T AT 86201704 T AT86201704 T AT 86201704T AT E66367 T1 ATE66367 T1 AT E66367T1
Authority
AT
Austria
Prior art keywords
polyethylene glycol
active substance
compositions
solution
micronized
Prior art date
Application number
AT86201704T
Other languages
English (en)
Inventor
Massimo Calanchi
Piergiorgio Rossi
Original Assignee
Eurand Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurand Spa filed Critical Eurand Spa
Application granted granted Critical
Publication of ATE66367T1 publication Critical patent/ATE66367T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Heat Treatment Of Sheet Steel (AREA)
AT86201704T 1985-10-15 1986-10-02 Verfahren zur herstellung von festen nifedipinzusammensetzungen mit verzoegerter abgabe und so erhaltene zusammensetzungen. ATE66367T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT22494/85A IT1187751B (it) 1985-10-15 1985-10-15 Procedimento per la preparazione di formulazioni solidi di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute
EP86201704A EP0220760B1 (de) 1985-10-15 1986-10-02 Verfahren zur Herstellung von festen Nifedipinzusammensetzungen mit verzögerter Abgabe und so erhaltene Zusammensetzungen

Publications (1)

Publication Number Publication Date
ATE66367T1 true ATE66367T1 (de) 1991-09-15

Family

ID=11197023

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86201704T ATE66367T1 (de) 1985-10-15 1986-10-02 Verfahren zur herstellung von festen nifedipinzusammensetzungen mit verzoegerter abgabe und so erhaltene zusammensetzungen.

Country Status (18)

Country Link
US (1) US4880623A (de)
EP (1) EP0220760B1 (de)
JP (1) JPH0811731B2 (de)
KR (1) KR940006320B1 (de)
AT (1) ATE66367T1 (de)
AU (1) AU590622B2 (de)
CA (1) CA1280976C (de)
DE (1) DE3680989D1 (de)
DK (1) DK168691B1 (de)
ES (1) ES2040209T3 (de)
FI (1) FI87424C (de)
GR (1) GR3003150T3 (de)
HK (1) HK12595A (de)
IT (1) IT1187751B (de)
NO (1) NO172168C (de)
NZ (1) NZ217841A (de)
PT (1) PT83522B (de)
ZA (1) ZA867767B (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8601624D0 (sv) * 1986-04-11 1986-04-11 Haessle Ab New pharmaceutical preparations
US5215752A (en) * 1988-03-17 1993-06-01 Vectorpharma International S.P.A. Pharmaceutical tablets and capsule granulates of scleroglucan and active substance
US5028433A (en) * 1988-11-30 1991-07-02 Banyu Pharmaceutical Co., Ltd. Readily absorbable drug formulation of NB-818
GB8903328D0 (en) * 1989-02-14 1989-04-05 Ethical Pharma Ltd Nifedipine-containing pharmaceutical compositions and process for the preparation thereof
HU203041B (en) * 1989-03-14 1991-05-28 Egyt Gyogyszervegyeszeti Gyar Process for producing pharmaceutical compositions of controlled releasing factor containing nifedipin
GB9025251D0 (en) * 1990-11-20 1991-01-02 Solomon Montague C Nifedipine dosage forms
US5145859A (en) * 1991-03-20 1992-09-08 Case Western Reserve University Methods of treating interstitial cystitis and urethral syndrome
US5271944A (en) * 1991-04-05 1993-12-21 Biofor, Ltd. Pharmacologically enhanced formulations
US5302397A (en) * 1991-11-19 1994-04-12 Amsden Brian G Polymer-based drug delivery system
IL104192A (en) * 1992-02-17 1998-01-04 Siegfried Ag Pharma Pharmaceutical dosage forms having prolonged release rate of zero order of the active ingredient
ATE135214T1 (de) * 1992-02-17 1996-03-15 Siegfried Ag Pharma Darreichungsformen mit verlaengerter wirkstoffreigabe
WO1994005262A1 (en) * 1992-09-10 1994-03-17 F.H. Faulding & Co. Limited Sustained release matrix composition
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5773025A (en) * 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
US6726930B1 (en) * 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5543099A (en) * 1994-09-29 1996-08-06 Hallmark Pharmaceutical, Inc. Process to manufacture micronized nifedipine granules for sustained release medicaments
US5618845A (en) * 1994-10-06 1997-04-08 Cephalon, Inc. Acetamide derivative having defined particle size
JP3148256B2 (ja) * 1996-07-08 2001-03-19 エドワード メンデル カンパニー．，インコーポレーテッド 高用量難溶性薬物用持続放出マトリックス
IT1284604B1 (it) * 1996-09-27 1998-05-21 Roberto Valducci Composizioni farmaceutiche a rilascio controllato per somministrazione orale contenenti nifedipina come sostanza attiva
US5922352A (en) * 1997-01-31 1999-07-13 Andrx Pharmaceuticals, Inc. Once daily calcium channel blocker tablet having a delayed release core
US5837379A (en) * 1997-01-31 1998-11-17 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
US6056977A (en) 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
US6485748B1 (en) 1997-12-12 2002-11-26 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
US8236352B2 (en) 1998-10-01 2012-08-07 Alkermes Pharma Ireland Limited Glipizide compositions
US8293277B2 (en) 1998-10-01 2012-10-23 Alkermes Pharma Ireland Limited Controlled-release nanoparticulate compositions
US7521068B2 (en) 1998-11-12 2009-04-21 Elan Pharma International Ltd. Dry powder aerosols of nanoparticulate drugs
ATE391495T1 (de) * 1999-09-30 2008-04-15 Penwest Pharmaceuticals Co Matrixsystem mit verzögerter freisetzung für hochlösliche wirkstoffe
BR0016555A (pt) 1999-12-23 2002-09-17 Pfizer Prod Inc Composições farmacêuticas que proporcionam concentrações acrescidas de droga
IL134701A0 (en) 2000-02-23 2001-04-30 J P M E D Ltd Homogeneous solid matrix containing vegetable proteins
US7198795B2 (en) 2000-09-21 2007-04-03 Elan Pharma International Ltd. In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
JP2004534811A (ja) * 2001-06-22 2004-11-18 ファイザー・プロダクツ・インク ポリマーと薬剤の集合体を含む医薬組成物
EP1269994A3 (de) * 2001-06-22 2003-02-12 Pfizer Products Inc. Pharmazeutische Zusammensetzungen die ein Arzneimittel und die Konzentration verbesserende Polymere enthalten
DE10142417A1 (de) * 2001-08-31 2003-03-20 Molecular And Clinical Drug Re Arzneimittel
DE10142416A1 (de) * 2001-08-31 2003-03-20 Molecular And Clinical Drug Re Verfahren zur Herstellung von Lösungen
WO2003033462A2 (en) * 2001-10-15 2003-04-24 The Regents Of The University Of Michigan Systems and methods for the generation of crystalline polymorphs
GB0205253D0 (en) * 2002-03-06 2002-04-17 Univ Gent Immediate release pharmaceutical granule compositions and a continuous process for making them
US20040048931A1 (en) * 2002-07-12 2004-03-11 Craig Heacock Modafinil pharmaceutical compositions
RU2219927C1 (ru) * 2002-11-21 2003-12-27 Азад Зияд Оглы Абышев Анкардин-retard - средство пролонгированного антикальциевого действия
WO2004075841A2 (en) * 2003-02-24 2004-09-10 Mallinckrodt Inc. Process for preparing benzhydrylthioacetamide
CA2519779A1 (en) * 2003-03-26 2004-10-14 Teva Pharmaceutical Industries Ltd. A process for preparing a pharmaceutical active ingredient with high specific surface area
US20040253308A1 (en) * 2003-04-29 2004-12-16 Barr Laboratories, Inc. Surface-treated modafinil particles
RU2255728C1 (ru) * 2004-03-04 2005-07-10 Азад Зияд Оглы Абышев Средство пролонгированного антикальциевого действия в виде 0,1% раствора для внутривенного введения
US7829713B2 (en) * 2006-02-28 2010-11-09 Helicon Therapeutics, Inc. Therapeutic piperazines
US20080181966A1 (en) * 2006-10-18 2008-07-31 Cephalon, Inc. Modafinil pharmaceutical compositions
WO2009007992A2 (en) * 2007-04-20 2009-01-15 Sun Pharmaceutical Industries Limited Pharmaceutical composition produced by microprecipitation
RU2629843C1 (ru) * 2016-05-24 2017-09-04 федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский университет) Способ получения мази нифедипина (варианты)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL251030A (de) * 1959-04-30
US3920809A (en) * 1973-11-05 1975-11-18 Lilly Co Eli Dibenzo(b,d)pyranone dispersions
US3988439A (en) * 1973-11-05 1976-10-26 Eli Lilly And Company Dibenzo[b,d]pyranone dispersions
DE2400819C2 (de) * 1974-01-09 1982-04-22 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung fester Zubereitungen von schwerlöslichen Arzneimittelwirkstoffen in feinster Verteilung
US4151273A (en) * 1974-10-31 1979-04-24 The Regents Of The University Of California Increasing the absorption rate of insoluble drugs
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
EP0001247A1 (de) * 1977-09-14 1979-04-04 Kanebo, Ltd. Nifedipine enthaltendes Arzneipräparat und Verfahren zu seiner Herstellung.
JPS55129221A (en) * 1979-03-29 1980-10-06 Kaken Pharmaceut Co Ltd Preparation of oral preparation containing hardly soluble medicine
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
US4311694A (en) * 1979-12-31 1982-01-19 American Cyanamid Company Amorphous coprecipitates of 4-(monoalkylamino) benzoic acid and derivatives and certain water-soluble materials
DE3033919A1 (de) * 1980-09-09 1982-04-22 Bayer Ag, 5090 Leverkusen Feste arzneizubereitungen enthaltend nifedipin und verfahren zu ihrer herstellung
DE3318649A1 (de) * 1983-05-21 1984-11-22 Bayer Ag, 5090 Leverkusen Zweiphasenformulierung
HU198844B (en) * 1984-06-14 1989-12-28 Sandoz Ag Process for producing new galenic pharmaceutical composition ensuring retarded release of active ingredient
IT1178511B (it) * 1984-09-14 1987-09-09 Pharmatec Spa Procedimento per la preparazione di una forma solida per uso orale a base di nifedipina con rilascio
DE3438830A1 (de) * 1984-10-23 1986-04-30 Rentschler Arzneimittel Nifedipin enthaltende darreichungsform und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
HK12595A (en) 1995-02-03
NZ217841A (en) 1990-01-29
NO864060L (no) 1987-04-21
FI87424C (fi) 1993-01-11
FI87424B (fi) 1992-09-30
NO172168B (no) 1993-03-08
DK168691B1 (da) 1994-05-24
JPS62167727A (ja) 1987-07-24
GR3003150T3 (en) 1993-02-17
KR940006320B1 (ko) 1994-07-16
PT83522B (pt) 1988-11-30
ZA867767B (en) 1987-06-24
ES2040209T3 (es) 1993-10-16
NO172168C (no) 1993-06-16
DK481186A (da) 1987-04-16
EP0220760A3 (en) 1987-09-23
DK481186D0 (da) 1986-10-08
FI864151A7 (fi) 1987-04-16
CA1280976C (en) 1991-03-05
PT83522A (en) 1986-11-01
KR870003779A (ko) 1987-05-04
EP0220760B1 (de) 1991-08-21
DE3680989D1 (de) 1991-09-26
NO864060D0 (no) 1986-10-13
FI864151A0 (fi) 1986-10-14
IT8522494A0 (it) 1985-10-15
US4880623A (en) 1989-11-14
IT1187751B (it) 1987-12-23
EP0220760A2 (de) 1987-05-06
AU590622B2 (en) 1989-11-09
JPH0811731B2 (ja) 1996-02-07
AU6383286A (en) 1987-04-16

Similar Documents

Publication Publication Date Title
ATE66367T1 (de) Verfahren zur herstellung von festen nifedipinzusammensetzungen mit verzoegerter abgabe und so erhaltene zusammensetzungen.
AU685784B2 (en) Excipient stabilization of polypeptides treated with organic solvents
US4578391A (en) Oily compositions of antitumor drugs
DE3910543A1 (de) Transdermales therapeutisches system mit erhoehtem wirkstofffluss und verfahren zu seiner herstellung
DE68916782T2 (de) Enterische formulierungen auf basis physiologisch aktiven peptiden und proteinen.
DK0460588T3 (da) Fremgangsmåde til fremstilling af hurtigt henfaldende af folie tilvirkede indgivningsformer
FI881409A0 (fi) Kantajakoostumus kestovaikutteiselle lääkeainevalmisteelle
NO842290L (no) Fremgangsmaate for fremstilling av preparater inneholdende oralt antidiabetisk aktive stoffer
JPS54147916A (en) Preparation of urokinase injection
US20080063626A1 (en) Minimization of drug oxidation in drug irradiated excipients formulations
JP2891744B2 (ja) パントテン酸カルシウム組成物およびその製造方法
JPS5649314A (en) Lasting pharmaceutical composition having prolonged action and its preparation
JPS5726615A (en) Improving method for absorbability of slightly soluble drug
EP0223033B1 (de) Verfahren zum gleichzeitigen Trocknen und Granulieren von Extraktstoffen aus enteiweisstem Kälberblut, nach diesem Verfahren erhaltenes Granulat und dessen Verwendung zur Herstellung von pharmazeutischen Präparaten
ES340549A1 (es) Un procedimiento para componer preparados de n-acetil-p-a- minofenol.
CA2304493A1 (en) Flavonolignan preparations, especially silymarin preparations
EP0794778A1 (de) Harzteilchen, medizinisches material und pharmazeutisches präparat, welches dieses harzteilchen enthält
JPH0135807B2 (de)
DE69112028T2 (de) Arzneizusammensetzungen zur rektalen Verabreichung enthaltend gefriergetrocknetes Calcitonin.
CN104940149A (zh) 一种复方氨林巴比妥注射冻干粉针剂及其制备方法
KR970005327B1 (ko) 인터페론 생산증강제 및 그 증강제를 사용한 인터페론 생산증강성 조성물
JPS55129220A (en) Composition for solid preparation containing hardly soluble medicinal component having rapid action and high bioavailability
ES484060A1 (es) Un procedimiento para la preparacion de una composicion con actividad diuretica
Wisudyaningsih et al. IAI SPECIAL EDITION: Effect of gelling agent and penetration enhancer on the release rate of ibuprofen-PEG 6000 solid dispersion from gel preparations
DE19548367A1 (de) Immunologisch wirksame Mistelextraktzubereitungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEFA Change of the company name
REN Ceased due to non-payment of the annual fee